<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-voriconazole.xml</id>
  <title>Recalls Watch: Voriconazole</title>
  <link rel="self" href="https://recalls.watch/feed/substance-voriconazole.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2025-04-16T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/96474/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Fenofibrate Capsules 67 mg and 38 more</title>
    <link href="https://recalls.watch/recall/fda/96474/"/>
    <updated>2025-04-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96574/</id>
    <title>Amerisource Health Services LLC: Voriconazole Tablets</title>
    <link href="https://recalls.watch/recall/fda/96574/"/>
    <updated>2025-04-09T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96209/</id>
    <title>Aspen Biopharma Labs Pvt., Ltd.: Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double… and 5 more</title>
    <link href="https://recalls.watch/recall/fda/96209/"/>
    <updated>2025-03-19T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/90982/</id>
    <title>Pharmacy Plus, Inc. dba Vital Care Compounder: ACETYLCYSTEINE OPTH 10% Solution and 31 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=90982"/>
    <updated>2022-11-09T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/65360/</id>
    <title>Lowlite Investments, Inc. D/B/A Olympia Pharmacy: Acetyl-D-Glucosamine w/Chondroitin 200 mg/ml and 104 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=65360"/>
    <updated>2013-07-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes</summary>
  </entry>
</feed>
